Literature DB >> 18573313

Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.

Seppo Helisalmi1, Timo Tarvainen, Saila Vepsäläinen, Anne Mari Koivisto, Mikko Hiltunen, Hilkka Soininen.   

Abstract

Single nucleotide polymorphisms (SNPs) in diabetes related peroxisome proliferator-activated receptor gamma (PPARG) gene were investigated with a case-control approach. To examine the genetic association of this gene with Alzheimer's disease (AD) risk, we used the TaqMan technique to genotype eight SNP sites for PPARG gene, in 538 Finnish AD cases and 672 controls and conducted a single allele and genotypic distribution comparison as well as estimated haplotype frequencies between cases and controls. No significant differences in AD risk were found in single SNP and haplotype analyses for PPARG gene between the study groups. We conclude that PPARG gene does not play a major role in the genetic predisposition to AD in the Finnish population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573313     DOI: 10.1016/j.neulet.2008.06.029

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Gene- Gene Interaction between PPARG and APOE Gene on Late-Onset Alzheimer's Disease: A Case- Control Study in Chinese Han Population.

Authors:  S Wang; L Guan; D Luo; J Liu; H Lin; X Li; X Liu
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

Review 2.  COMT Val158Met and PPARγ Pro12Ala polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Neurol Sci       Date:  2014-01-30       Impact factor: 3.307

3.  Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia.

Authors:  Nobuto Shibata; Yumiko Motoi; Hiroyuki Tomiyama; Tohru Ohnuma; Bolati Kuerban; Katrin Tomson; Miwa Komatsu; Hiromi Shimazaki; Nobutaka Hattori; Heii Arai
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-05-18

4.  Impact and Therapeutic Potential of PPARs in Alzheimer's Disease.

Authors:  Michael T Heneka; Elisabet Reyes-Irisarri; Michael Hüll; Markus P Kummer
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

5.  Interaction between PPAR γ and SORL1 gene with Late-Onset Alzheimer's disease in Chinese Han Population.

Authors:  Hui Zhang; Wei Zheng; Linlin Hua; Yutong Wang; Jinfeng Li; Hongying Bai; Shanshan Wang; Mingyao Du; Xuelian Ma; Chunyang Xu; Xiaodong Li; Bin Gong; Yunliang Wang
Journal:  Oncotarget       Date:  2017-07-18

6.  Pharmacological Targets and the Biological Mechanisms of Formononetin for Alzheimer's Disease: A Network Analysis.

Authors:  Hai Xiao; Xinyue Qin; Jinping Wan; Rong Li
Journal:  Med Sci Monit       Date:  2019-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.